WASHINGTON — By now we've all heard that the Pfizer COVID-19 vaccine has an efficacy rate of 95%, Moderna of 94%, and Johnson & Johnson about 66%; what you may not have known is that rate's technical ...
IN THIS issue of the Journal of Clinical Oncology, Chao et al 1 report the results of a study that examined the impact of using four different risk/benefit measures when communicating survival ...
DEAR DR. ROACH: Could you please explain the percentages that are given when a study indicates an increase for a particular risk? For example, say a person with mild coronary artery disease is at an ...
Treatment effects are often anticipated to vary across groups of patients with different baseline risk. The Predictive Approaches to Treatment Effect Heterogeneity (PATH) statement focused on baseline ...
WASHINGTON — By now we've all heard that the Pfizer COVID-19 vaccine has an efficacy rate of 95%, Moderna of 94%, and Johnson & Johnson about 66%; what you may not have known is that rate's technical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results